Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1978 2
1979 1
1981 1
1982 1
1984 1
1986 1
1987 3
1988 4
1989 1
1991 6
1993 3
1994 1
1995 3
1996 2
1997 5
1999 1
2000 5
2002 4
2003 2
2004 4
2005 3
2008 1
2009 2
2011 1
2014 1
2015 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D, Martin WH. Delbeke D, et al. Semin Nucl Med. 2004 Jul;34(3):209-23. doi: 10.1053/j.semnuclmed.2004.03.006. Semin Nucl Med. 2004. PMID: 15202102 Review.
The evaluation of patients with known or suspected recurrent colorectal carcinoma is now an accepted indication for positron emission tomography using (18)F-fluorodeoxyglucose (FDG-PET) imaging. ...
The evaluation of patients with known or suspected recurrent colorectal carcinoma is now an accepted indication for pos …
Positron emission tomography for evaluation of colorectal carcinoma.
Vitola J, Delbeke D. Vitola J, et al. Semin Roentgenol. 2002 Apr;37(2):118-28. doi: 10.1016/s0037-198x(02)80031-1. Semin Roentgenol. 2002. PMID: 12134365 Review.
Evaluation of patients with known or suspected recurrent colorectal carcinoma is now an accepted indication for FDG PET imaging. ...
Evaluation of patients with known or suspected recurrent colorectal carcinoma is now an accepted indication for FDG PET …
Surgical salvage therapy: abdominoperineal resection for recurrent anal carcinoma, metastasectomy of recurrent colorectal cancer, and esophagectomy after combined chemoradiation.
Chao C, Goldberg M, Hoffman JP. Chao C, et al. Curr Opin Oncol. 2000 Jul;12(4):353-6. doi: 10.1097/00001622-200007000-00012. Curr Opin Oncol. 2000. PMID: 10888421 Review.
Although this is not yet the case for esophageal carcinoma, recent improved chemoradiation regimens have been reported by the French and Japanese, who use surgery for nonresponders. For recurrent colorectal carcinoma, including liver-only metastases, patients …
Although this is not yet the case for esophageal carcinoma, recent improved chemoradiation regimens have been reported by the French and Jap …
FDG-PET scanning in the diagnosis of gastrointestinal cancers.
van Kouwen MC, Oyen WJ, Nagengast FM, Jansen JB, Drenth JP. van Kouwen MC, et al. Scand J Gastroenterol Suppl. 2004;(241):85-92. doi: 10.1080/00855920410014614. Scand J Gastroenterol Suppl. 2004. PMID: 15696855 Review.
Large series have indicated that the sensitivity and specificity for detecting recurrent colorectal carcinoma are in the range of 87%-100% and 66%-100%, respectively. ...
Large series have indicated that the sensitivity and specificity for detecting recurrent colorectal carcinoma are in th …
Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis.
Zhang C, Chen Y, Xue H, Zheng P, Tong J, Liu J, Sun X, Huang G. Zhang C, et al. Int J Cancer. 2009 Jan 1;124(1):167-73. doi: 10.1002/ijc.23926. Int J Cancer. 2009. PMID: 18844237 Free article.
Accurate detection of recurrent colorectal carcinoma remains a diagnostic challenge. The purposes of this study were to evaluate the diagnostic value of Positron emission tomography (PET) using fluor-18-deoxyglucose (FDG) in recurrent colorectal …
Accurate detection of recurrent colorectal carcinoma remains a diagnostic challenge. The purposes of this study were to …
The accuracy of computed tomography in the pretreatment staging of colorectal cancer.
Tan YN, Li XF, Li JJ, Song YM, Jiang B, Yang J, Yuan Y. Tan YN, et al. Hepatogastroenterology. 2014 Jul-Aug;61(133):1207-12. Hepatogastroenterology. 2014. PMID: 25436284 Review.
And positron emission tomography (PET) or PET/CT is recommended as a complement of CT, only for cases suspected of residual or recurrent colorectal carcinoma or before metastasectomy, not for routine use....
And positron emission tomography (PET) or PET/CT is recommended as a complement of CT, only for cases suspected of residual or recurrent …
Colorectal cancer: the role of PET/CT in recurrence.
Vogel WV, Wiering B, Corstens FH, Ruers TJ, Oyen WJ. Vogel WV, et al. Cancer Imaging. 2005 Nov 23;5 Spec No A(Spec No A):S143-9. doi: 10.1102/1470-7330.2005.0034. Cancer Imaging. 2005. PMID: 16361130 Free PMC article. Review.
Many imaging modalities and scanning techniques, such as contrast enhanced CT, MRI and FDG-PET, are available for assessment of recurrent colorectal carcinoma. In addition, integrated PET/CT is becoming increasingly available. ...In this review we evaluate th …
Many imaging modalities and scanning techniques, such as contrast enhanced CT, MRI and FDG-PET, are available for assessment of recurrent …
The approach to the patient with single and multiple liver metastases, pulmonary metastases, and intra-abdominal metastases from colorectal carcinoma.
VanderMeer TJ, Callery MP, Meyers WC. VanderMeer TJ, et al. Hematol Oncol Clin North Am. 1997 Aug;11(4):759-77. doi: 10.1016/s0889-8588(05)70459-7. Hematol Oncol Clin North Am. 1997. PMID: 9257154 Review.
Recurrent colorectal carcinoma constitutes a major health care problem, with 90,000 patients diagnosed annually with metastatic disease. ...
Recurrent colorectal carcinoma constitutes a major health care problem, with 90,000 patients diagnosed annually with me …
Whole-body FDG-PET imaging in the management of patients with cancer.
Hustinx R, Bénard F, Alavi A. Hustinx R, et al. Semin Nucl Med. 2002 Jan;32(1):35-46. doi: 10.1053/snuc.2002.29272. Semin Nucl Med. 2002. PMID: 11839068 Review.
Convincing data also exist to support the use of PET for evaluating patients with recurrent colorectal carcinoma, for staging and restaging lymphomas, and for diagnosing recurrent thyroid carcinoma in the presence of elevated thyroglobulin and negative 131I s …
Convincing data also exist to support the use of PET for evaluating patients with recurrent colorectal carcinoma, for s …
Staging recurrent metastatic colorectal carcinoma with PET.
Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr, Chapman WC, Pinson CW. Delbeke D, et al. J Nucl Med. 1997 Aug;38(8):1196-201. J Nucl Med. 1997. PMID: 9255148 Free article.
Accurate detection of recurrent colorectal carcinoma remains a diagnostic challenge. The purposes of this study were to assess the accuracy of 18FDG-PET in patients with recurrent colorectal carcinoma in detecting liver metastases compare …
Accurate detection of recurrent colorectal carcinoma remains a diagnostic challenge. The purposes of this study were to …
62 results